Skip to main content
    C

    Corbus Pharmaceuticals Holding (CRBP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.41
    -0.37 (-7.74%)

    Market Cap: $101.73M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    44%(17/39)
    Avg Surprise
    -4.59%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-1.21
    Range$-1.91 - $-0.73
    10 analysts
    EPS Revisions
    2
    0
    7d
    2
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$-1.03-17.4%
    60d ago$-1.03-17.4%
    30d ago$-1.210.0%
    7d ago$-1.210.0%
    Current$-1.21
    Revenue Consensus
    $1M
    Range$0 - $10M
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-1.76
    Range$-3.14 - $-0.39
    10 analysts
    Revenue Consensus
    $0
    Range$-1111110 - $9M
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.76---
    Sep 26EST
    		-$-1.21---
    Jun 26
    Reported Aug 6
    		$-1.81$-1.30-39.23%Miss-25.7%
    Mar 26
    Reported May 12
    		$-1.23$-1.22-0.82%Miss+11.5%
    Dec 25
    Reported Mar 9
    		$-1.25$-1.58+20.69%Beat-60.3%
    Sep 25
    Reported Nov 12
    		$-1.90$-1.71-11.11%Miss-65.2%
    Jun 25
    Reported Aug 5
    		$-1.44$-1.33-8.27%Miss-60.0%
    Mar 25
    Reported May 6
    		$-1.39$-1.07-29.91%Miss-67.5%
    Dec 24
    Reported Mar 11
    		$-0.78$-1.26+38.04%Beat+56.9%
    Sep 24
    Reported Nov 7
    		$-1.15$-0.95-21.05%Miss+49.3%
    Jun 24
    Reported Aug 6
    		$-0.90$-1.19+24.37%Beat+56.1%
    Mar 24
    Reported May 7
    		$-0.83$-1.09+23.85%Beat+80.4%
    Dec 23
    Reported Mar 12
    		$-1.81$-2.36+23.31%Beat+30.7%
    Sep 23
    Reported Nov 7
    		$-2.27$-2.06-10.19%Miss-8.1%
    Jun 23
    Reported Aug 8
    		$-2.05$-3.10+33.87%Beat+37.9%
    Mar 23
    Reported May 9
    		$-4.24$-4.09-3.67%Miss-76.7%
    Dec 22
    Reported Mar 7
    		$-2.61$-2.10-24.29%Miss-8.8%
    Sep 22
    Reported Nov 8
    		$-2.10$-1.65-27.27%Miss-250.0%
    Jun 22
    Reported Aug 9
    		$-3.30$-1.80-83.33%Miss+26.7%
    Mar 22
    Reported May 10
    		$-2.40$-2.55+5.88%Beat+42.9%
    Dec 21
    Reported Mar 8
    		$-2.40$-3.22+25.47%Beat+20.0%
    Sep 21
    Reported Nov 12
    		$-0.60N/A+81.82%Beat+95.3%
    Jun 21
    Reported Aug 12
    		$-4.50$-3.75-20.00%Miss+71.2%
    Mar 21
    Reported May 13
    		$-4.20$-4.80+12.50%Beat+67.4%
    Dec 20
    Reported Mar 15
    		$-3.00N/A+60.32%Beat+75.6%
    Sep 20
    Reported Nov 10
    		$-12.90$-12.18-5.91%Miss-34.4%
    Jun 20
    Reported Aug 6
    		$-15.60$-11.25-38.67%Miss-1833.3%
    Mar 20
    Reported May 11
    		$-12.90$-12.70-1.57%Miss+0.0%
    Dec 19
    Reported Mar 12
    		$-12.30$-10.74-14.53%Miss-36.7%
    Sep 19
    Reported Nov 7
    		$-9.60$-10.90+11.93%Beat-23.1%
    Jun 19
    Reported Aug 8
    		$0.90N/A+108.43%Beat+114.3%
    Mar 19
    Reported May 9
    		$-12.90$-4.45-189.89%Miss-104.8%
    Dec 18
    Reported Mar 12
    		$-9.00$-7.80-15.38%Miss-42.9%
    Sep 18
    Reported Nov 8
    		$-7.80$-6.65-17.29%Miss-85.7%
    Jun 18
    Reported Aug 8
    		$-6.30$-6.45+2.33%Beat-40.0%
    Mar 18
    Reported May 10
    		$-6.30$-4.10-53.66%Miss-31.3%
    Dec 17
    Reported Mar 12
    		$-6.30$-4.62-36.36%Miss-16.7%
    Sep 17
    Reported Nov 8
    		$-4.20$-4.80+12.50%Beat-
    Jun 17
    Reported Aug 9
    		$-4.50$-5.60+19.64%Beat-
    Mar 17
    Reported May 9
    		$-4.80$-4.80+0.00%Beat-
    Dec 16
    Reported Mar 9
    		$-5.40$-4.10-31.71%Miss-

    Key Metrics

    Valuation
    P/E Ratio-0.71EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-95.60%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio5.71xQuick Ratio5.71x
    Trading Statistics
    Beta2.63Avg Volume1.01M
    52-Week High$20.5652-Week Low$4.76

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.47
    SMA 20$6.38
    SMA 50$8.53
    SMA 200$8.85
    EMA 10$5.46
    EMA 20$6.30
    EMA 50$7.68
    EMA 200$8.85

    MACD

    Line: -1.06Signal: -0.96Hist: -0.10

    ADX

    ADX: 54.1+DI: 6.2-DI: 42.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$5.54

    Bollinger Bands

    Upper Band$8.50
    Lower Band$4.26
    %B Position6643%(Upper)
    Band Width0.03

    RSI (14-Day)

    Oversold
    17.8

    Momentum Oscillators

    Stoch %K2.5
    Stoch %D4.6
    Williams %R-98.8
    ROC (10d)-35.3%
    Momentum-2.41
    CCI (20d)-144.7
    MFI (14d)N/A

    Volatility Measures

    ATR (14d)$0.52(11.7%)
    StdDev (20d)1.06
    Hist Vol58.4%(High)

    Volume Flow

    VWAP$4.53
    OBV-26.3M
    AD Line-14.0M
    CMF (20d)-0.368

    Volume Metrics

    Avg Vol (20d)859.4K
    Vol Ratio1.6x(High)
    VWMA (20d)$6.23

    Pivot Points

    R3$5.61
    R2$5.43
    R1$5.11
    Pivot Point$4.93
    S1$4.61
    S2$4.43
    S3$4.11

    Advanced Oscillators

    TSI-52.85
    Ultimate Osc24.1
    KST-372.42

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.16M$1.40M$1.41M$1.13M$1.31M$1.68M$4.71M$0$1.60M$0$1.64M$0
    Cost of Revenue$0$0$49,000$0$0$0$146,000$0$0$0$147,978$0
    Gross Profit$1.16M$1.40M$1.41M$1.13M$1.31M$1.68M$4.71M$0$1.60M$0$1.64M$0
    Operating Expenses$36.19M$48.61M$43.93M$48.83M$19.15M$39.55M$50.34M$15.51M$21.98M$9.62M$20.21M$18.98M
    R&D$31.18M$19.82M$18.41M$20.86M$15.19M$15.64M$8.79M$10.81M$6.87M$5.76M$6.98M$6.55M
    SG&A$5.01M$4.49M$3.56M$3.56M$3.96M$4.13M$3.82M$4.70M$4.12M$3.86M$3.12M$2.94M
    Operating Income$-36,190,000$-24,304,000$-21,966,000$-24,417,000$-19,152,000$-19,775,000$-12,605,000$-15,505,000$-10,988,000$-9,623,000$-10,103,975$-9,488,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$19.19M$0$0$0$24.11M$381,000$652,000$839,000$1.64M$763,000
    Income Before Tax$-35,037,000$-46,046,000$-41,160,000$-46,648,000$-17,662,000$-34,014,000$-36,716,000$-15,686,000$-20,053,000$-7,927,000$-16,037,999$-20,090,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-35,037,000$-45,938,000$-41,110,000$-46,684,000$-17,662,000$-33,956,000$-19,060,000$-27,566,000$-19,994,000$-13,798,000$-16,044,376$-20,106,000
    EBITDA$-36,376,000$-23,441,000$-21,247,000$-23,356,000$-19,343,000$-16,043,000$-4,387,000$-15,710,000$-10,689,000$-7,657,000$-5,671,046$-9,629,000
    EBIT$-36,201,000$-23,144,000$-20,604,000$-23,356,000$-18,976,000$-15,920,000$-3,694,000$-15,305,000$-10,013,000$-7,088,000$-5,929,046$-9,839,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CRBP

    News

    Corbus Pharmaceuticals stock costs EUR 3.86 with volume 36.43 percent above average

    Corbus Pharmaceuticals (CRBP) stock was trading at EUR 3.86 on October 15, 2026, with a trading volume of 1,089,233 shares, which is 36.43% above its average. The company, focused on oncology and obesity treatments...

    ad-hoc-news.de•10/15/26•Neutral

    A throat cancer trial doses its first patient as Corbus (CRBP) reports CRB-701 response data.

    Corbus Pharmaceuticals has reported promising efficacy data for its CRB-701 oncology program, showing a 42.9% confirmed objective response rate in oropharyngeal squamous cell carcinoma patients at 3.6 mg/kg. The company...

    Stock Titan•10/15/26•Bullish

    Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors

    Corbus Pharmaceuticals Holdings Inc. (CRBP) stock dropped 7.74% on Wednesday, closing at $4.41. This underperformance occurred during a negative trading session for the broader market...

    MarketWatch•10/14/26•Bearish

    Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors

    Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) fell 9.30% to $4.78 on Tuesday, marking its second consecutive day of losses. This underperformance occurred during a generally negative trading session for the stock...

    MarketWatch•10/13/26•Bearish

    Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors

    Corbus Pharmaceuticals Holdings Inc. (CRBP) stock decreased by 2.04% on Monday, closing at $5.27. This underperformance occurred on a mixed trading day...

    MarketWatch•10/12/26•Bearish

    CRBP Valuation and Fair Value

    P/E
    -0.7x
    PEG
    0.0x
    P/B
    0.8x
    See GNG's fair value

    CRBP Profitability: Margins, ROIC and FCF

    Gross margin
    100.0%
    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -95.6%
    FCF margin
    -1699.4%

    CRBP Competitors

    CompanyTicker
    Inovio Pharmaceuticals IncINO
    Humacyte IncHUMA
    Unicycive Therapeutics IncUNCY
    The Joint CorpJYNT
    PDS Biotechnology CorpPDSB
    PolyPidPYPD
    Armata Pharmaceuticals IncARMP
    Coya Therapeutics, Inc. Common StockCOYA

    Sector: Healthcare

    CRBP Analyst Ratings

    Consensus
    Buy
    Analysts
    10
    Strong Buy
    1
    Buy
    9
    Hold
    0
    Sell
    0
    Strong Sell
    0

    CRBP Bull Case vs Bear Case

    Bull case

    • 100.0% of CRBP's analyst ratings are Buy or Strong Buy.

    Bear case

    • CRBP beat EPS estimates in 25.0% of its last 8 reported quarters.
    • CRBP's quarterly revenue changed -100.0% year over year.

    CRBP Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -6.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-1.21
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 7 down

    Frequently Asked Questions About CRBP

    Does CRBP pay dividends?

    Corbus Pharmaceuticals Holding (CRBP) does not currently pay a regular dividend.

    What is CRBP's market cap?

    Corbus Pharmaceuticals Holding (CRBP) has a market capitalization of $101.73M with a current stock price of $4.41.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In